Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer

Korean Journal of Laboratory Medicine

Volumn 28, Issue 6, 2008, Pages 425-429

  Im, Mijeong ^a   Lee, Jin Kyung ^a,b   Hong, Young Joon ^a,b   Hong, Seok Il ^a,b   Kang, Hye Jin ^a   Na, Im Il ^a   Ryoo, Baek Yeol ^a   Cheon, Gi Jeong ^a   Lee, Ha Na ^b   Chang, Yoon Hwan ^a,b  

^a Korea Cancer Center Hospital   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Radioisotope therapy; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD DISEASE; CASE REPORT; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 9; FEMALE; GENE DELETION; GENE TRANSLOCATION; GENETICS; HUMAN; LEUKEMIA; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; SECOND CANCER; THYROID TUMOR; THYROIDECTOMY;

ADULT; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENE DELETION; HEMATOLOGIC NEOPLASMS; HUMANS; IODINE RADIOISOTOPES; LEUKEMIA, RADIATION-INDUCED; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THYROID NEOPLASMS; THYROIDECTOMY; TRANSLOCATION, GENETIC;

EID: 62349094749     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.6.425     Document Type: Article

References (21)

1. The Korean Society of Hematology. Hematology. 1st ed. Seoul: EPublic, 2006:291-4.
2. Wang KL, Lin LY, Chen PM, Lin HD. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc 2005;68:230-3.
3. Pochin EE. Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 1967;18:113-25.
4. Maxon HR, Thomas SR, Chen IW. The role of nuclear medicine in the treatment of hyperthyroidism and well-differentiated thyroid adenocarcinoma. Clin Nucl Med 1981;6:87-98.
5. Hoffman DA, McConahey WM, Fraumeni JF Jr, Kurland LT. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol 1982;11:218-24. (Pubitemid 12019143)
6. Hall P, Boice JD Jr, Berg G, Bjelkengren G, Ericsson UB, Hallquist A, et al. Leukaemia incidence after iodine-131 exposure. Lancet 1992;340:1-4.
7. Lee SH, Eom KS, Lee S, Kim HJ, Min CK, Kim SY, et al. A case of acute promyelocytic leukemia after iodine-131 treatment for thyroid cancer. Korean J Hematol 2006;41:302-5.
8. Ko TY, Kwag JS, Oh KS, Lee SB, Chung BS, Kim ES, et al. Acute myelogenous leukemia developed after radioactive iodine therapy and palliative radiation therapy in metastatic papillary thyroid cancer. Korean J Nucl Med 1998;32;436-42.
9. Yoon T, Kim DY, Lee KW, Kim DH, Yoon SS, Park SY, et al. A case of therapy-related acute lymphoblastic leukemia after 131I-treatment for thyroid papillary carcinoma. Korean J Intern Med 2004;66: 437-41.
10. Piccirillo N, Sora F, Laurenti L, Sica S, Chiusolo P, Leone G. Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer. Haematologica 1999;84:1050-1.
11. Laurenti L, Salutari P, Sica S, Piccirillo N, Zini G, Zollino M, et al. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders. Ann Hematol 1998;76:271-2. (Pubitemid 28321083)
12. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1638-44. (Pubitemid 37464133)
13. Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, et al. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett 2006;238:42-52. (Pubitemid 43851143)
14. Sankar R, Sekhri T, Sripathy G, Walia RP, Jain SK. Radioactive iodine therapy in Graves'hyperthyroidism: a prospective study from a tertiary referral centre in north India. J Assoc Physicians India 2005; 53:603-6. (Pubitemid 41280032)
15. Brincker H, Hansen HS, Andersen AP. Induction of leukemia by 131-I treatment of thyroid carcinoma. Br J Cancer 1973;28:232-7.
16. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998;280:347-55. (Pubitemid 28503219)
17. Shimon I, Kneller A, Olchovsky D. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol (Oxf) 1995;43:651-4.
18. Bitton R, Sachmechi I, Benegalrao Y, Schneider BS. Leukemia after a small dose of radioiodine for metastatic thyroid cancer. J Clin Endocrinol Metab 1993;77:1423-6. (Pubitemid 23345508)
19. Roldan Schilling V, Fernandez Abellan P, Dominguez Escribano JR, Rivas Gonzalez C, Mut Barbera E, Calatayud Cendra R. Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica 1998;83:767-8.
20. Grudeva-Popova J, Yaneva M, Zisov K, Ananoshtev N. Therapyrelated acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review. J BUON 2007;12:129-32. (Pubitemid 46830280)
21. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)